(WEST LAFAYETTE) - The Purdue Research Foundation is licensing new technology to a San Diego company that could be mass-produced into a bird flu vaccine.
The vaccine technology transports an extra gene related to the influenza virus. The extra gene produces a protein in the host's cells and triggers an immune response against bird flu.
The process still needs approval from the food and drug administration.
Have a question or comment about a news story? Send it to email@example.com